Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Announces Departure of CEO

GlobeNewswire September 11, 2018

Kane Biotech Announces Second Quarter 2018 Financial Results

GlobeNewswire August 21, 2018

Kane Biotech Schedules Second Quarter 2018 Earnings Conference Call and Business Update

GlobeNewswire August 15, 2018

Kane Biotech Achieves DTC Eligibility in the United States

GlobeNewswire August 14, 2018

Kane Biotech Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

GlobeNewswire August 9, 2018

Kane Biotech and the U.S. Army Institute of Surgical Research Sign Extension of Cooperative Research and Development Agreement

GlobeNewswire July 31, 2018

Kane Biotech Retains Market-Making Services

GlobeNewswire July 24, 2018

Kane Biotech Announces Closing of Loan Transaction

GlobeNewswire July 17, 2018

Kane Biotech to Showcase bluestem™ Pet Oral Care Products and New Skin Care Shampoo at SuperZoo

GlobeNewswire June 21, 2018

Kane Biotech to Present at The MicroCap Conference in Toronto

GlobeNewswire June 14, 2018

Kane Biotech to Showcase Technologies and Products at the 2018 BIO International Convention

GlobeNewswire June 1, 2018

IIROC Trading Resumption - KNE

Canada NewsWire May 31, 2018

Kane Biotech Granted Wound Care Patent from the U.S. Patent and Trademark Office

GlobeNewswire May 31, 2018

IIROC Trading Halt - KNE

Canada NewsWire May 31, 2018

InvestmentPitch Media Invites Investors to the TakeStock Alberta Investor Forum in Calgary on May 31, 2018 - Video Hosted on InvestmentPitch.com

Newsfile May 30, 2018

Kane Biotech to Present at TakeStock! Investor Forum

GlobeNewswire May 24, 2018

Kane Biotech Announces First Quarter 2018 Financial Results, Granting of Options and Investor Relations Improvements

GlobeNewswire May 17, 2018

Kane Biotech Schedules First Quarter 2018 Earnings Conference Call and Business Update

GlobeNewswire May 10, 2018

Kane Biotech to Present at The MicroCap Conference

GlobeNewswire April 5, 2018

Kane Biotech – 2017 Year End and Fourth Quarter Financial Results and Business Update

GlobeNewswire March 21, 2018